From single-sequences to evolutionary trajectories: protein language models capture the evolutionary potential of SARS-CoV-2

Read full text
Authors: Kieran D. Lamb, Joseph Hughes Hughes, Spyros Lytras, Francesca Young, Orges Koci, James Herzig, Simon C. Lovell, Joe Grove, Ke Yuan, David L. Robertson
Cited by: 7
References: 63

Abstract

Protein language models (PLMs) capture features of protein three-dimensional structure from amino acid sequences alone, without requiring multiple sequence alignments (MSA). The concepts of grammar and semantics from natural language have been suggested to have the potential to capture functional properties of proteins. Here, we investigate how these representations enable assessment of variation due to mutation. Applied to the SARS-CoV-2 spike protein via in silico deep mutational scanning (DMS), the PLM ESM-2 captures evolutionary constraints directly from sequence context, recapitulating what normally requires MSA data. Unlike other state-of-the-art methods which require protein structures or multiple sequences for training, we show what can be accomplished using an unmodified pretrained PLM. Applied to SARS-CoV-2 variants across the pandemic, we demonstrate that ESM-2 representations encode the evolutionary history between variants, as well as the distinct nature of variants of concern upon their emergence, associated with shifts in receptor binding and antigenicity. ESM-2 likelihoods can also identify epistatic interactions among sites in the protein. Our results here affirm that PLMs like ESM-2 are broadly useful for variant-effect prediction, including unobserved changes, and can be applied to understand novel viral pathogens with the potential to be applied to any protein sequence, pathogen or otherwise.

Fields of Study & Subjects

Machine Learning in Bioinformatics SARS-CoV-2 and COVID-19 Research vaccines and immunoinformatics approaches

Publication details

Journal / source
Nature Communications
Publisher
Springer Science and Business Media LLC
Volume
17
Issue
1
Publication date
19 February 2026
Language
EN